Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson’s disease progression-Reference-Cited by-同舟云学术

Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson’s disease progression

Published:2021-03 Issue:3 Volume:1 Page:309-322
ISSN:2662-8465
Container-title:Nature Aging
language:en
Short-container-title:Nat Aging

Author:

Kern Fabian,Fehlmann Tobias^ORCID,Violich Ivo,Alsop Eric,Hutchins Elizabeth^ORCID,Kahraman Mustafa,Grammes Nadja L.,Guimarães Pedro,Backes Christina,Poston Kathleen L.,Casey Bradford^ORCID,Balling Rudi,Geffers Lars,Krüger Rejko^ORCID,Galasko Douglas,Mollenhauer Brit,Meese Eckart,Wyss-Coray Tony^ORCID,Craig David W.,Van Keuren-Jensen Kendall,Keller Andreas^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Link

http://www.nature.com/articles/s43587-021-00042-6.pdf

Reference56 articles.

1. Wang, H. et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1459–1544 (2016).

2. Deweerdt, S. Parkinson’s disease: 4 big questions. Nature 538, S17 (2016).

3. Kalia, L. V. & Lang, A. E. Parkinson’s disease. Lancet 386, 896–912 (2015).

4. Jankovic, J. Parkinson’s disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 79, 368–376 (2008).

5. Hamza, T. H. et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease. Nat. Genet. 42, 781–785 (2010).

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of ADAR editing and nonsense-mediated decay in Parkinson’s Disease;2024-05-21

2. Experimental capture of miRNA targetomes: disease-specific 3′UTR library-based miRNA targetomics for Parkinson’s disease;Experimental & Molecular Medicine;2024-04-01

3. How close are we to a breakthrough? The hunt for blood biomarkers in Parkinson's disease diagnosis;European Journal of Neuroscience;2024-02-21

4. The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson’s Disease: a New Genetic State of the Art;Molecular Neurobiology;2024-02-13

5. An Integrative Network Approach for Longitudinal Stratification in Parkinson’s Disease;2024-01-25